US 7067109
Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids
granted A61KA61K39/395A61K47/6835
Quick answer
US patent 7067109 (Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids) held by The Board of Regents of the University of Texas System expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K39/395, A61K47/6835, A61K47/6849, A61K49/04